abstract |
The present invention relates to a pharmaceutical composition for treating hepatitis B, and more particularly, tanshinol B, tanshinone IIB, prchebaquinone A, salvia (Salvia miltiorrhiza Bunge) extract represented by the following general formulas (1), (2) and (3). Salvia miltiorrhiza Bunge fraction containing as an active ingredient relates to a pharmaceutical composition useful for the treatment of hepatitis B. |